With our digital pathology solution** you can digitize your workflow with consistently high image quality and fast first-time-right scanning capabilities. Maximize diagnostic confidence and high throughput with a first-time-right rate of 99.5%*, enabling laboratory efficiency and fast turnarounds, thanks to a new scanner platform with a range of high-performing digital scanner models.
IntelliSite Image Management System features software and algorithms designed to aid your efficiency, streamline workflow and maximize diagnostic confidence. This enhances the user experience by combining fast and easy digital workflow with smart case load management to allow for real-time collaboration and case sharing for improved patient care.*
An updated case viewer enables multi-disciplinary patient data review and care pathway selection.
Share across organizations and among sites through an open solution that enables enhanced interoperability options. Share across organizations and among sites through an open solution that enables enhanced interoperability options.
lluminate a new path to precision care. Unleash the power of fully integrated solutions. Discover our user-friendly, clinically proven portfolio of integrated diagnostic informatics solutions.
Philips helps bring more clarity at every moment of cancer care through streamlined multidisciplinary workflows and integrated patient data. See how.
*Survey of 52 pathologists, lab managers and lab technicians in Europe, 2018. Results are specific to the institution where they were obtained and may not reflect the results achievable at other institutions. **The digital pathology solution is a bundle of: Pathology Scanner Second Generation SG20/ SG60/ SG300 • Image Management System Viewer • Image Management System Application Server and Storage Software • High quality 27” monitor validated with the IVD solution (US only) Under the EUA ,the use of PIPS in the USA was allowed and now with the end of the EUA ,Philips Is pursuing a 510k clearance for the PIPS device. Philips IntelliSite Pathology Solution is in conformance with Regulation (EU) 201 7/746 of the European Parliament and of the Council of 5 April 2017 on In Vitro Diagnostics (IVDR).
You are about to visit a Philips global content page
ContinueThe information on this site is not intended for consumers. The information is directed exclusively to health professionals, health practitioners, persons who are purchasing officers in hospitals, and persons who are engaged in the business of wholesaling therapeutic goods (as per s42AA of the Therapeutic Goods Act 1989 (Cth), and s6 of the Therapeutic Goods (Therapeutic Goods Advertising Code) Instrument 2021).
By clicking “Continue” you are indicating that you are one of the intended audiences. Click cancel to be redirected to the Philips website.